ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 317 filers reported holding ROYALTY PHARMA PLC in Q2 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,028,661 | -2.5% | 37,902 | +10.4% | 0.68% | +0.3% |
| Q2 2023 | $1,055,304 | -15.5% | 34,330 | -1.0% | 0.68% | -16.9% |
| Q1 2023 | $1,249,520 | +6.6% | 34,680 | +16.9% | 0.82% | +0.7% |
| Q4 2022 | $1,172,163 | -6.5% | 29,660 | -4.9% | 0.81% | -14.8% |
| Q3 2022 | $1,253,000 | -48.8% | 31,176 | -48.4% | 0.95% | +14.9% |
| Q2 2022 | $2,445,000 | +109.7% | 60,362 | +101.6% | 0.83% | +11.3% |
| Q1 2022 | $1,166,000 | -1.4% | 29,939 | +0.9% | 0.74% | +5.8% |
| Q4 2021 | $1,183,000 | +43.9% | 29,682 | +30.5% | 0.70% | +22.9% |
| Q3 2021 | $822,000 | -12.0% | 22,747 | -0.2% | 0.57% | -12.3% |
| Q2 2021 | $934,000 | – | 22,797 | – | 0.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $244,378,000 | 79.54% |
| Vantage Consulting Group Inc | 7,862,542 | $284,152,000 | 60.85% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $96,878,000 | 60.36% |
| Indie Asset Partners, LLC | 701,323 | $25,346,000 | 20.53% |
| HARVARD MANAGEMENT CO INC | 7,142,856 | $258,143,000 | 15.13% |
| Bleichroeder LP | 1,115,980 | $40,332,000 | 6.55% |
| Overbrook Management Corp | 785,132 | $28,375,000 | 6.16% |
| Geo Capital Gestora de Recursos Ltd | 194,305 | $7,022,000 | 3.21% |
| Brown University | 621,759 | $22,470,000 | 3.05% |
| Graypoint LLC | 610,584 | $22,067,000 | 2.71% |